Epilepsia Waves is an innovative a ssociation dedicated to improving the quality of life for people with epilepsy. The association brings together patients, caregivers, healthcare professionals, and multidisciplinary experts to co-create solutions tailored to patient needs. Inspired by the “Mozart effect,” it explores the impact of music as a non-invasive approach to reducing the frequency and severity of seizures.
At the heart of the project is Eva Menard, an artist and epilepsy patient, who transformed her personal experience into a driving force for designing a pioneering study on how people with epilepsy perceive music. Her ambition is to create a modern, scientifically validated musical repertoire, designed to accompany patients daily while adhering to strict quality and regulatory standards.
How was a one-week clinical trial deployed to 250 patients without technical hurdles?
“Datacapt makes clinical research more humane and effective by combining modern technology with a deep understanding of patient needs”
Eva MenardFounder & Artist
92%
Completion Rate
5 days
To launch the study
250
patients enrolled
100%
control and visibility
Who is Epilepsia Waves?
Context and Challenge
Obstacles to Overcome
Epilepsia Waves faced several hurdles in implementing its ambitious project. The main obstacle was the inadequacy of tools and methods offered by the initial CRO, whose rigid, inflexible framework did not support an iterative, patient-centric approach.
At the same time, the complex regulatory requirements—notably GDPR and Good Clinical Practice (GCP)—hindered the team’s autonomy and slowed project progress. Additionally, some technological solutions featured interfaces unsuited to users who may experience cognitive impairments linked to epilepsy, making them difficult to use in this context.
Traditional clinical approaches failed to align with the association’s patient-first vision, making it crucial to identify a customized solution.
The solution
A Tailor-Made Response
In this context, the association turned to Datacapt to meet its specific needs. From the very first exchanges, they were struck by the responsiveness and active listening of the Datacapt team, which immediately grasped the project’s stakes. It soon became clear they had found more than a vendor—a true partner.
The platform’s intuitive interface and comprehensive features quickly exceeded expectations. Fully compliant with quality, security, and regulatory requirements, it provided a robust, reliable framework. Clinicians, physicians, and the CRO unanimously confirmed the appropriateness of the choice.
In just four days, the team configured, tested, and deployed its survey with no prior technical experience. Targeted training and responsive support enabled rapid mastery of the tool, along with guidance to optimize the survey.
With Datacapt, questionnaire distribution is automated, response tracking is streamlined, and real-time adjustments can be made at any stage. Freed from technical constraints, the team can focus on patient follow-up and project success.
Tangible Benefits – Measurable Results
Within seven days, the survey was built, tested among study stakeholders, refined, validated, and sent to 250 patients. Responses began flowing in immediately. The completion rate reached an impressive 92% in the first phase, without any specialized training for participants, thanks to a simple information note.
What would have taken several weeks using a traditional approach was accomplished in just a few days. Epilepsia Waves estimates it reduced survey preparation time by four. No administrative or logistical effort was required during fieldwork, thanks to automated dispatches aligned with each stage of the trial. The team could concentrate on patient monitoring and support.
Moreover, exported data are instantly formatted and ready for immediate analysis, with no additional processing needed.
”In just a few days, I was able to configure and test my survey, allowing me to focus on what really matters: patient well-being
Eva MenardFounder & Artist
Conclusion
Being patient centric
The Epilepsia Waves experience illustrates the ongoing revolution in clinical trials. Patients want to be fully engaged in advancing science, placing their needs at the forefront and forging strong connections with medical and clinical teams.
This project demonstrates that it is possible to conduct a rigorous, compliant, and scientifically robust study while preserving speed and autonomy. With Datacapt, teams gain a powerful tool to manage complex clinical projects with ease, agility, and responsiveness. Beyond technology, they receive tailored advice and support at every stage.
For those looking to save time, ensure data reliability, and better engage patients, Datacapt is far more than a tool: it is a strategic partner rooted in strong values. Together, let’s transform the world of clinical trials—while honoring its heritage.
Ready to take action? Contact Datacapt today and bring your clinical projects to life.
